Matches in Nanopublications for { ?s ?p "DDI between Rosiglitazone and Tretinoin - The moderate CYP2C8 inhibitor, Rosiglitazone, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Rosiglitazone is initiated, discontinued to dose changed. [drugbank_resource:DB00412_DB00755]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00412_DB00755 label "DDI between Rosiglitazone and Tretinoin - The moderate CYP2C8 inhibitor, Rosiglitazone, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Rosiglitazone is initiated, discontinued to dose changed. [drugbank_resource:DB00412_DB00755]" assertion.